Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic: An Observational Study
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 主要终点
- Geographical distribution of the interventional studies after 11th of March 2020.
研究概览
简要总结
On 11th of March 2020, WHO characterized COVID-19 infection as a Pandemic. After the COVID-19 infection is declared as a Pandemic there was an outburst regarding COVID-19 Research. The Research interest led to registration of Interventional and Observational studies world wide. There are constant efforts by Health care workers to seek information regarding the Interventional and Observational studies which can help in decision making regarding effective handling of COVID-19 infected patients. It is also important to track on the happenings in various frontiers of COVID-19 Research in view of historical interest and clinical relevance. This Observational Cross sectional study aims to explore the completed Researches in WHO-compliant registries to understand the trends of COVID-19 Research. This study aims to get a birds eye view of ongoing COVID-19 Research scenario worldwide. This study results can directly benefit the worldwide Academicians and Health Care Professionals to understand the ongoing COVID-19 Research trends.
详细描述
On 11th of March 2020, WHO characterized COVID-19 infection as a Pandemic. After the COVID-19 infection is declared as a Pandemic there was an outburst regarding COVID-19 Research. The Research interest led to registration of Interventional and Observational studies world wide.
AIMs & Objectives of the Study This Observational Cross sectional study aims to explore the completed Researches in WHO-compliant registries to understand the trends of COVID-19 Research.
This study results can directly benefit the worldwide Academicians and Health Care Professionals to understand the ongoing COVID-19 Research trends.
Primary Outcomes of the Study To understand the geographical distribution of the interventional studies after 11th of March 2020.
To understand the geographical distribution of the Observational studies after 11th of March 2020.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 1 Year 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Interventional studies in the WHO-compliant registries database which are registered and completed after 11th of March 2020 until 15th of August
- •Observational studies in the WHO-compliant registries database which are registered and completed after 11th of March 2020 until 15th of August 2020.
排除标准
- •Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March
- •Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
研究组 & 干预措施
Completed Interventional studies
Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Convalescent Plasma Transfusion (Drug)
Completed Interventional studies
Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Hydroxychloroquine (Drug)
Completed Interventional studies
Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: DAS181 (Drug)
Completed Interventional studies
Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Ivermectin (Drug)
Completed Interventional studies
Interventional studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Interferon Beta-1A (Drug)
Completed Observational studies
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Convalescent Plasma Transfusion (Drug)
Completed Observational studies
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Hydroxychloroquine (Drug)
Completed Observational studies
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: DAS181 (Drug)
Completed Observational studies
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Ivermectin (Drug)
Completed Observational studies
Observational studies in the WHO-compliant registries database which are registered and completed before 11th March 2020.
干预措施: Interferon Beta-1A (Drug)
结局指标
主要结局
Geographical distribution of the interventional studies after 11th of March 2020.
时间窗: 15th of August 2020
To understand the geographical distribution of the interventional studies after 11th of March 2020.
Geographical distribution of the Observational studies after 11th of March 2020.
时间窗: 15th of August 2020
To understand the geographical distribution of the Observational studies after 11th of March 2020.
Monthly Research study completion rate as per geographic distribution of the Research.
时间窗: 15th of August 2020
To understand the monthly Research study completion rate as per geographic distribution of the Research.
次要结局
- Statistical correlation of the interventional studies Research with developed, developing and under developed countries.(15th of August 2020)
- Statistical correlation of the observational studies Research with developed, developing and under developed countries.(15th of August 2020)
- Statistical correlation of the Drug based interventional studies Research with developed, developing and under developed countries.(15th of August 2020)
- Statistical correlation of the Diagnostic test based interventional studies Research with developed, developing and under developed countries.(15th of August 2020)
- Statistical correlation of the Device based interventional studies Research with developed, developing and under developed countries.(15th of August 2020)
研究者
Dr Shiva Shankar Bugude
Assistant Professor
Qassim University